MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 12.35
-0.30 (-2.37%)
At close: May 8, 2026
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 799.3 million as of May 8, 2026. Its market cap has increased by 33.51% in one year.
Market Cap
799.30M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.35
Market Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 799.30M, a decrease of -62.18%. That is a compound annual growth rate of -19.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 799.30M | -0.80% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.06B |
| U-Neuron Biomedical | 1.04B |
| Taiwan Advance Bio-Pharmaceutical | 967.50M |
| TCI GENE | 952.51M |
| NatureWise Biotech & Medicals | 893.05M |
| Neith | 793.51M |
| BioLASCO Taiwan | 755.55M |
| SynCore Biotechnology Co.,Ltd | 720.87M |